hers compounded semaglutide safety "semaglutide" is not FDA-approved HERS COMPANY COMPOUND SEMAGLUTIDE EXPERIANCE?

2 mg NDC 0169-4772-12List 477212 OZEMPIC (semaglutide) injection For Single Patient Use Only 8 mg/3 mL (2.68 mg/mL) Prefilled pen Pen delivers 4 doses of 2 mg only For subcutaneous use only Use OZEMPIC once weekly Contains: 1 OZEMPIC pen, 4 NovoFine Plus 32G needles, Product Literature

This unique pharmacological profile has generated considerable scientific interest in understanding its potential effects on metabolic regulation, body weight, glucose homeostasis, and energy expenditure

Coutinho W, Halpern B

When combined with Semaglutide in the CagriSema protocol, weight loss exceeded 22%, showing Cagrilintide has strong synergistic potential with the GLP-1 pathway

Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism

Glucagon also stimulates hepatic glucose output in the fasted state, which drives fat oxidation